Daily Morning Note

24 November 2022

Current % % Market Commentary

Indices
Value 1D YTD
Sensex 61,511 0.1 5.6  Asian Markets: Asian markets are trading higher tracking positive cues from
Nifty 18,267 0.1 5.3 Wall Street overnight. Nikkei is trading higher 1.18%, Hang Seng is trading
BSE Midcap 25,268 0.2 1.2 higher by 0.30% and Shanghai is trading flattish.
BSE Small cap 28,878 0.5 -2.0  Indian Indices: Indian indices are expected to open higher. Sgx Nifty was
SGX Nifty Fut. 18,312 -0.19 NA
trading higher by 0.48%.
Sectors – Performance (BSE)
Oil & Gas 19,757 0.7 12.8
 US Markets: The US markets ended higher following the release of the

Bankex 48,827 0.7 20.8 minutes of the Federal Reserve's meeting, which indicated the central bank is
Metal 19,918 0.6 3.5 considering slowing the pace of its interest rate hikes. The Dow gained 96
Capital Goods 33,412 -0.3 16.2 points or 0.3 % to 34,194, the Nasdaq gained 111 points or 1% to 11,285.
Tech 13,910 -0.2 -16.3
Consumer Dur 41,004 -0.2 -8.4 News in Focus
 IPO Listing : Keystone Realtors (Rustomjee) will debut on the stock
Nifty
CMP % Chg exchanges. The issue price has been fixed at Rs 541/ share.
Gainers/Losers
APOLLOHOSP 4,605 3.0  Can Fin Homes board to consider interim dividend at meeting to be held on
JSWSTEEL 721 1.7 November 28,2022.
SBIN 608 1.4  Biocon has entered a semi-exclusive partnership agreement with European
ADANIENT 3,903 (3.2) pharmaceutical company Zentiva for the commercialisation of its vertically
POWERGRID 215 (1.2) integrated, complex formulation, Liraglutide, a drug-device combination for the
ADANIPORTS 874 (1.0) treatment and management of type 2 diabetes and obesity. Additionally,
Biocaon has also issued commercial papers worth Rs 2,250 Cr on private
FII Trading activities in Cash placement basis at a coupon of 7.75%.
Date Net MTD
 Adani Power: Supreme Court upheld Aptel order on Rs 7,000 Cr transmission
FII 23-Nov-22 -790 -1,488
contract awarded by MERC to Adani Electricity Mumbai Infra. Tata Power had
DII 23-Nov-22 414 1,050
challenged this order in April 2021.
Figs. in Rs Cr.

Current % %  Shoppers Stop has made an investment of Rs 4.95 Cr in wholly owned

Global Indices
Value 1D YTD subsidiary Global SS Beauty Brands under an earlier commitment to inject Rs
Dow Jones 34,194 0.3 11.7 20 Cr in the unit.
NASDAQ 11,285 1.0 (12.4)
 Neuland Laboratories board approved transfer of company’s property spanning
DAX 14,428 0.0 5.2
1.75 lakh square feet in Nanakramguda, Hyderabad to various parties via
Nikkei 225 28,460 1.2 3.7
perpetual lease for an overall consideration of Rs 117.96 Cr.
FTSE 100 7,465 0.2 15.6
 Tamilnad Mercantile Bank has entered into corporate agency agreement with
Hang Seng 17,649 0.7 (35.2)
Cholamandalam MS General Insurance Company and Max Life Insurance
Shanghai A Sha 3,101 0.1 (10.7)
Source: Bloomberg; As on 7:30 am IST
Company for marketing, distribution and selling life and general insurance

Forex Rate products.

INR/USD 81.9 -0.2 -9.2
INR/EUR 84.5 -0.7 -0.3
INR/GBP 97.6 -0.7 2.9
INR/YEN (100) 57.9 -0.1 11.6

For private circulation only 1

Investment Picks
Target %
Company Recommendation CMP
Price Upside
Aarti Drugs Ltd BUY 453 545 20.4
ACC Ltd BUY 2,460 2,760 12.2
Aditya Birla Fashion & Retail Ltd BUY 306 400 30.7
Ahluwalia Contracts (India) Ltd BUY 439 485 10.6
Amber Enterprises India Ltd BUY 1,953 3,000 53.6
Aptus Value Housing Finance India Ltd BUY 315 370 17.5
Ashok Leyland Ltd BUY 145 175 20.3
Asian Paints Ltd BUY 3,101 3,500 12.9
Astral Ltd BUY 1,896 2,500 31.8
AU Small Finance Bank Ltd BUY 624 750 20.2
Bajaj Auto Ltd BUY 3,608 4,000 10.9
Bajaj Finance Ltd BUY 6,780 8,250 21.7
Bandhan Bank Ltd BUY 215 305 41.7
Bata India Ltd BUY 1,697 1,950 14.9
Bharti Airtel Ltd BUY 843 960 13.8
Birla Corporation Ltd BUY 955 1,110 16.2
Camlin Fine Sciences Ltd BUY 157 190 21.1
Can Fin Homes Ltd BUY 526 650 23.7
CCL Products (India) Ltd BUY 502 600 19.6
Cholamandalam Investment & Finance Company
BUY 719 845 17.6
Ltd
Cipla Ltd BUY 1,108 1,300 17.3
City Union Bank Ltd BUY 185 225 21.7
Coal India Ltd BUY 231 275 19.3
Coforge Ltd BUY 3,874 4,275 10.3
Colgate-Palmolive (India) Ltd BUY 1,589 1,750 10.2
CreditAccess Grameen Ltd BUY 954 1,200 25.9
Dabur India Ltd BUY 551 650 17.9
DCB Bank Ltd BUY 122 145 18.5
Dr Reddys Laboratories Ltd BUY 4,406 5,000 13.5
Eicher Motors Ltd BUY 3,381 4,125 22.0
Embassy Office Parks REIT BUY 340 400 17.6
Equitas Small Finance Bank Ltd BUY 53 60 14.0
G R Infraprojects Ltd BUY 1,165 1,600 37.4
H. G. Infra Engineering Ltd BUY 573 835 45.7
HDFC Bank Ltd BUY 1,599 1,800 12.6
Hindalco Industries Ltd BUY 433 515 18.8
Hindustan Unilever Ltd BUY 2,507 2,810 12.1
ICICI Securities Ltd BUY 524 625 19.3
IDFC First Bank Ltd BUY 57 70 22.8
IndiaMART InterMESH Ltd BUY 4,341 5,280 21.6
For private circulation only 2
 Investment Picks
Target %
Company Recommendation CMP
Price Upside
Indian Hotels Company Ltd BUY 318 360 13.1
Infosys Ltd BUY 1,583 1,750 10.5
ITC Ltd BUY 340 400 17.7
J K Cements Ltd BUY 2,953 3,350 13.4
JK Lakshmi Cement Ltd BUY 645 745 15.5
KNR Constructions BUY 239 330 37.9
Kotak Mahindra Bank Ltd BUY 1,953 2,300 17.7
Krishna Institute of Medical Sciences Ltd BUY 1,498 1,740 16.2
Manappuram Finance Ltd BUY 112 175 57.0
Maruti Suzuki India Ltd BUY 8,935 10,270 14.9
MAS Financial Services Ltd BUY 883 1,050 18.9
Minda Corporation Ltd BUY 208 255 22.8
Mold-Tek Packaging Ltd BUY 880 1,021 16.0
Nestle India Ltd BUY 19,565 22,000 12.4
Nippon Life India Asset Management Ltd BUY 258 360 39.8
NOCIL Ltd BUY 230 300 30.3
Oriental Carbon & Chemicals Ltd BUY 764 950 24.4
P I Industries Ltd BUY 3,376 3,830 13.4
Persistent Systems Ltd BUY 3,722 4,265 14.6
PNC Infratech Ltd BUY 276 340 23.1
Praj Industries Ltd BUY 390 477 22.3
SBI Cards & Payment Services Ltd BUY 799 1,075 34.6
SBI Life Insurance Company Ltd BUY 1,226 1,540 25.6
SIS Ltd BUY 389 475 22.1
Star Cement Ltd BUY 104 115 11.1
State Bank of India BUY 608 740 21.8
Sundaram Finance Ltd BUY 2,257 2,490 10.3
Tata Steel Ltd BUY 105 117 11.0
Tech Mahindra Ltd BUY 1,044 1,200 14.9
Trent Ltd BUY 1,410 1,650 17.0
TVS Motor Company Ltd BUY 1,052 1,230 16.9
Ujjivan Small Finance Bank Ltd BUY 29 34 19.1
UNO Minda Industries Ltd BUY 561 620 10.4
V Mart Retail Ltd BUY 2,779 3,500 25.9
Varun Beverages Ltd BUY 1,165 1,300 11.6
Westlife Development Ltd BUY 757 930 22.8

For private circulation only 3

 Index CMP % Chng S2 S1 P R1 R2
Nifty 18,267.25 0.13% 18200 18235 18280 18315 18360
Sensex 61,510.58 0.15% 61240 61375 61580 61715 61915
Bank Nifty 42,729.10 0.64% 42410 42570 42715 42875 43020

Nifty opened with an upward gap and remained lackluster within a narrow trading range throughout the day. Nifty closed at 18267
with a gain of 23 points.

On the daily chart the index has formed a small Bearish candle however it forms a higher High-Low compared to previous session
indicating positive bias. The index is moving in a Higher Top and Higher Bottom formation on the daily chart indicating a sustained
up trend. The chart pattern suggests that if Nifty crosses and sustains above 18300 level it would witness buying which would
lead the index towards 18400-18500 levels. Important Support for the day is around 18200 However if index sustains below
18200 then it may witness profit booking which would take the index towards 18100-18000 levels.. Nifty is trading above 20, 50,
100 and 200 day SMA indicating positive bias in the short to medium term. Nifty continues to remain in an uptrend for the short
term, so buying on dips continues to be our preferred strategy.

The daily strength indicator RSI continues to remain flat and is below its reference line indicating absence of momentum on either
side

The trend deciding level for the day is 18215. If NIFTY trades above this level then we may witness a further rally up to 18290-
18340-18415 levels. However, if NIFTY trades below 18215 levels then we may see some profit booking initiating in the market,
which may correct up to 18165-18090-18045 levels

STOCK IDEAS FOR THE DAY

Company Name Buy / Sell Range Stop Loss Target
HINDPETRO Buy above 216 214 218/220
TORNTPHARM Sell below 1614 1630 1598/1580

Note- Stocks Ideas are based on previous day’s close and are activated only if they trade in buy/sell range.

For private circulation only 4

Corporate Action Tracker

Dividend (BSE 500 universe)

Dividend Per
Security Code Security Name Purpose Ex-Date Record Date
Share
CONTAINER CORPORATION OF INDIA
531344 Interim Dividend 22-Nov-22 23-Nov-22 3
LTD.
500125 E.I.D.-PARRY (INDIA) LTD. Interim Dividend 22-Nov-22 23-Nov-22 5.5
500620 GREAT EASTERN SHIPPING CO.LTD. Interim Dividend 22-Nov-22 23-Nov-22 7.2
524494 IPCA LABORATORIES LTD. Interim Dividend 22-Nov-22 23-Nov-22 4
531213 MANAPPURAM FINANCE LTD. Interim Dividend 22-Nov-22 23-Nov-22 0.75
500188 HINDUSTAN ZINC LTD. Interim Dividend 23-Nov-22 24-Nov-22 15.5
500493 BHARAT FORGE LTD. Interim Dividend 24-Nov-22 25-Nov-22 1.5
523405 JM FINANCIAL LTD.-$ Interim Dividend 24-Nov-22 25-Nov-22 0.9
532810 POWER FINANCE CORPORATION LTD. Interim Dividend 24-Nov-22 25-Nov-22 3
500295 Vedanta Limited Interim 29-Nov-22 30-Nov-22

Bulk Deals (Mcap> 1000 Cr.)

Mcap Quantity Trade Value
Date Security Name Acquirer/Seller B/S
(In Cr.) Traded Price (In Cr.)
23-Nov-22 Mazagon Dock Shipbuil Ltd 5,925 GRAVITON RESEARCH CAPITAL LLP SELL 12,64,424 895 113
23-Nov-22 Mazagon Dock Shipbuil Ltd 5,925 GRAVITON RESEARCH CAPITAL LLP BUY 12,64,424 895 113
23-Nov-22 Voltamp Transformers Limi 1,905 NALANDA INDIA FUND LIMITED SELL 4,20,000 2,652 111
23-Nov-22 Voltamp Transformers Limi 1,905 NIPPON INDIA MUTUAL FUND BUY 3,00,000 2,650 80
23-Nov-22 Rashtriya Chem Fert Ltd. 5,084 QE SECURITIES SELL 31,53,926 115 36
23-Nov-22 Rashtriya Chem Fert Ltd. 5,084 QE SECURITIES BUY 30,74,779 115 35
23-Nov-22 Easy Trip Planners Ltd 8,689 GRAVITON RESEARCH CAPITAL LLP SELL 51,44,271 68 35
23-Nov-22 Easy Trip Planners Ltd 8,689 GRAVITON RESEARCH CAPITAL LLP BUY 51,44,271 68 35
23-Nov-22 Rashtriya Chem Fert Ltd. 5,084 XTX MARKETS LLP SELL 29,72,878 114 34
23-Nov-22 Rashtriya Chem Fert Ltd. 5,084 XTX MARKETS LLP BUY 29,72,265 114 34
CAPRI GLOBAL HOLDINGS PRIVATE
23-Nov-22 Fino Payments Bank Ltd 2,395 BUY 13,19,853 229 30
LIMITED
23-Nov-22 Easy Trip Planners Ltd 8,689 QE SECURITIES BUY 35,13,449 68 24
23-Nov-22 Easy Trip Planners Ltd 8,689 QE SECURITIES SELL 34,91,920 69 24
23-Nov-22 Easy Trip Planners Ltd 8,689 NIRAJ RAJNIKANT SHAH BUY 32,03,088 69 22
23-Nov-22 Easy Trip Planners Ltd 8,689 SW CAPITAL PRIVATE LIMITED SELL 30,13,372 69 21
23-Nov-22 Easy Trip Planners Ltd 8,689 SKSE SECURITIES LTD SELL 28,85,347 69 20
23-Nov-22 Easy Trip Planners Ltd 8,689 SKSE SECURITIES LTD BUY 28,85,347 69 20
23-Nov-22 Easy Trip Planners Ltd 8,689 SW CAPITAL PRIVATE LIMITED BUY 19,61,405 67 13
23-Nov-22 Easy Trip Planners Ltd 8,689 NIRAJ RAJNIKANT SHAH SELL 16,89,902 69 12
23-Nov-22 Mazagon Dock Shipbuil Ltd 5,925 GRAVITON RESEARCH CAPITAL LLP SELL 12,64,424 895 113

For private circulation only 5

Trading Insights
Insight from trading volumes

Total Volume Monthly Avg

Script CMP % Change
(x1000) Volume(x1000)

HDFCLIFE 548 5,678 2,811 102.0%

NESTLEIND 19,565 87 54 61.1%

INDUSINDBK 1,174 3,405 2,615 30.2%

CIPLA 1,108 2,227 1,804 23.4%

POWERGRID 215 11,980 10,670 12.3%

EICHERMOT 3,381 808 789 2.4%

SBILIFE 1,226 891 872 2.2%

Insight from delivery

Monthly Avg
Total Delivery
Script CMP Delivery %Change
Volume(x1000)
Volume(x1000)
WIPRO 389 7,483 3,023 147.5%

GAIL 91 10,467 6,991 49.7%

INDUSINDBK 1,174 1,646 1,125 46.3%

JSWSTEEL 721 918 673 36.3%

IOC 70 8,541 6,367 34.1%

BPCL 310 1,889 1,505 25.5%

BHARTIARTL 843 4,954 3,993 24.1%

*CMP-Closing Market Price

For private circulation only 6

Daily Support/ Resistance of Nifty Companies
Company CMP Pivot Point R1 R2 S1 S2
NIFTY 50 18,267 18,280 18,313 18,359 18,234 18,200
ADANIPORTS 874 877 884 895 866 858
ASIANPAINT 3,101 3,102 3,114 3,127 3,088 3,076
AXISBANK 875 874 879 883 870 865
BAJAJ-AUTO 3,608 3,619 3,642 3,677 3,584 3,561
BAJAJFINSV 1,636 1,642 1,653 1,670 1,625 1,614
BAJFINANCE 6,780 6,758 6,827 6,874 6,712 6,643
BHARTIARTL 843 846 850 856 839 835
BPCL 310 309 312 314 307 304
BRITANNIA 4,155 4,163 4,186 4,217 4,132 4,109
CIPLA 1,108 1,110 1,122 1,136 1,096 1,085
COALINDIA 231 230 231 232 229 228
DIVISLAB 3,300 3,306 3,317 3,333 3,289 3,278
DRREDDY 4,406 4,395 4,430 4,454 4,371 4,336
EICHERMOT 3,381 3,392 3,408 3,435 3,364 3,348
GAIL 91 91 91 92 90 89
GRASIM 1,703 1,703 1,713 1,723 1,693 1,683
HCLTECH 1,103 1,105 1,110 1,117 1,098 1,093
HDFC 2,637 2,638 2,651 2,665 2,624 2,610
HDFCBANK 1,599 1,601 1,607 1,616 1,592 1,586
HDFCLIFE 548 546 551 554 543 537
HEROMOTOCO 2,659 2,669 2,688 2,716 2,640 2,621
HINDALCO 433 435 438 442 430 427
HINDUNILVR 2,507 2,512 2,523 2,538 2,497 2,486
ICICIBANK 927 928 932 936 924 920
INDUSINDBK 1,174 1,173 1,185 1,195 1,163 1,151
INFY 1,583 1,585 1,590 1,598 1,578 1,572
IOC 70 70 70 71 70 69
ITC 340 340 342 344 338 335
JSWSTEEL 721 717 726 731 712 703
KOTAKBANK 1,953 1,953 1,961 1,969 1,946 1,938
LT 2,025 2,029 2,040 2,055 2,014 2,002
M&M 1,236 1,233 1,243 1,250 1,226 1,217
MARUTI 8,935 8,942 8,982 9,030 8,894 8,854
NESTLEIND 19,565 19,629 19,746 19,926 19,449 19,332
NTPC 168 168 169 169 167 166
ONGC 137 136 137 138 135 134
POWERGRID 215 216 218 221 213 212
RELIANCE 2,557 2,563 2,573 2,589 2,547 2,536
SBILIFE 1,226 1,226 1,235 1,244 1,217 1,208
SBIN 608 606 611 615 603 598
SHREECEM 23,288 23,276 23,399 23,510 23,165 23,043
SUNPHARMA 1,018 1,015 1,021 1,025 1,012 1,006
TATAMOTORS 424 425 428 432 422 419
TATASTEEL 105 105 106 106 105 104
TCS 3,308 3,310 3,329 3,349 3,289 3,270
TECHM 1,044 1,048 1,055 1,065 1,038 1,031
TITAN 2,602 2,609 2,626 2,650 2,585 2,568
ULTRACEMCO 6,824 6,843 6,886 6,947 6,781 6,738
UPL 769 770 774 780 765 761
WIPRO 389 390 392 395 387 385
Source: Axis Direct.

For private circulation only 7

Disclosures:

The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).

1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH000000297. ASL, the Research Entity (RE) as defined
in the Regulations, is engaged in the business of providing Stock broking services, Depository participant services & distribution of various financial
products. ASL is a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India’s largest private sector bank and
has its various subsidiaries engaged in businesses of Asset management, NBFC, Merchant Banking, Trusteeship, Venture Capital, Stock Broking,
the details in respect of which are available on www.axisbank.com.
2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities and with the
Association of Mutual Funds of India (AMFI) for distribution of financial products and also registered with IRDA as a corporate agent for insurance
business activity.
3. ASL has no material adverse disciplinary history as on the date of publication of this report.
4. I/We, authors (Research team) and the name/s subscribed to this report, hereby certify that all of the views expressed in this research report
accurately reflect my/our views about the subject issuer(s) or securities. I/We (Research Analyst) also certify that no part of my/our compensation
was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL or its
Associate does not have any financial interest in the subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial
ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report.
Since associates of ASL are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various
companies including the subject company/companies mentioned in this report. I/we or my/our relative or ASL or its associate does not have any
material conflict of interest. I/we have not served as director / officer, employee, etc. in the subject company in the last 12-month period.

Research Team
Sr. No Name Designation E-mail
1 Rajesh Palviya Technical & Derivative Analyst - (Head) rajesh.palviya@axissecurities.in
2 VaishnaviJagtap Technical Analyst vaishnavi.jagtap@axissecurities.in
3 RahilVora Derivative Analyst rahil.vora@axissecurities.in
4 HemangGor Derivative Analyst hemang.gor@axissecurities.in
5 Hiren Trivedi Research Associate hiren.trivedi@axissecurities.in

5. ASL or its Associates has not received any compensation from the subject company in the past twelve months. I/We or ASL or its Associate has not
been engaged in market making activity for the subject company.
6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, ASL or any of
its associates may have:
i. Received compensation for investment banking, merchant banking or stock broking services or for any other services from the subject
company of this research report and / or;
ii. Managed or co-managed public offering of the securities from the subject company of this research report and / or;
iii. Received compensation for products or services other than investment banking, merchant banking or stock broking services from the subject
company of this research report;

ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other third-party in
connection with this report.

Term& Conditions:
This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly
confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in
any form, without prior written consent of ASL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate.
The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable.
Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy,
completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose
and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though
disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ASL will not treat recipients as customers by
virtue of their receiving this report.

For private circulation only 8

Disclaimer:

Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable
or appropriate to the recipient’s specific circumstances. The securities and strategies discussed and opinions expressed, if any, in this report
may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial
positions and needs of specific recipient.

This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should
make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies
referred to in this report (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of
such an investment. Certain transactions, including those involving futures, options and other derivatives as well as non-investment grade
securities involve substantial risk and are not suitable for all investors. ASL, its directors, analysts or employees do not take any responsibility,
financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report,
including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction
in the dividend or income, etc. Past performance is not necessarily a guide to future performance. Investors are advise necessarily a guide to
future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the
securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and
may be subject to change without notice.

ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell
the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities or earn brokerage or
other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or
investment banker, lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any
recommendation and other related information and opinions. Each of these entities functions as a separate, distinct and independent of each
other. The recipient should take this into account before interpreting this document.

ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a
result, the recipients of this report should be aware that ASL may have a potential conflict of interest that may affect the objectivity of this
report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service
transactions. ASL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in
this report.

Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed,
directly or indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof. If this report is
inadvertently sent or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of
the sender. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located
in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation
or which would subject ASL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may
not be eligible for sale in all jurisdictions or to certain category of investors.

The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated
as endorsement of the views expressed in the report. The Company reserves the right to make modifications and alternations to this
document as may be required from time to time without any prior notice. The views expressed are those of the analyst(s) and the Company
may or may not subscribe to all the views expressed therein.

Copyright in this document vests with Axis Securities Limited.

Axis Securities Limited, SEBI Single Reg. No.- NSE, BSE & MSEI – INZ000161633, ARN No. 64610, CDSL-IN-DP-CDSL-693-2013, SEBI-
Research Analyst Reg. No. INH 000000297, SEBI Portfolio Manager Reg. No.- INP000000654, Main/Dealing off.- 1st Floor, I-Rise Building,
Q Parc, Loma Park, Thane, Ghansoli, Navi Mumbai-400701, Regd. off.- Axis House,8th Floor, Wadia International Centre,
PandurangBudhkar Marg, Worli, Mumbai – 400 025. Compliance Officer: AnandShaha, Email: compliance.officer@axisdirect.in, Tel No: 022-
49212706

For private circulation only 9